Revlimid-NIS: Non-interventional study on therapy of relapsed/refractory multiple myeloma with a combination of lenalidomide plus dexamethasone

被引：0
|
作者：
Knauf, W. [1 ]
Aldaoud, A. [2 ]
Maintz, C. [3 ]
Groschek, M. [4 ]
Teichmann, B. [5 ]
Harde, J. [5 ]
Trarbach, T. [5 ]
机构：
[1] Ctr Hamatol & Onkol Bethanien, Frankfurt, Germany
[2] Gemeinschaftspraxis Hamatol Onkol, Leipzig, Germany
[3] Hamatol Onkol Praxis, Wurselen, Germany
[4] Hamatol Onkol Stolberg, Stolberg, Germany
[5] iOMEDICO AG, Freiburg, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P783
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] Therapy of relapsed/refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone: First interim analysis of the non-interventional study "Revlimid"
    Knauf, W.
    Aldaoud, A.
    Groschek, M.
    Teichmann, B.
    Harde, J.
    Hasskarl, J.
    [J]. ONKOLOGIE, 2013, 36 : 154 - 155
  • [2] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
  • [3] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [4] Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials
    Knauf, Wolfgang
    Aldaoud, Ali
    Losem, Christoph
    Mittermueller, Johann
    Neise, Michael
    Niemeier, Beate
    Harde, Johanna
    Trarbach, Tanja
    Potthoff, Karin
    [J]. LEUKEMIA RESEARCH, 2018, 68 : 90 - 97
  • [5] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    [J]. BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [6] Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 555 - 560
  • [7] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    [J]. BLOOD, 2011, 118 (21) : 1266 - 1267
  • [8] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [9] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [10] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    [J]. BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
12345